Evaluate effectiveness of ReCET™ device for improving blood sugar control in individuals with T2D.

Please fill in your details

Please enter first name.

Please enter last name.

Please enter valid email.

Please enter valid contact number.

Please select type of diabetes.

About the Study

This research aims to evaluate the safety and effectiveness of a device called ReCET™ for improving blood sugar control in individuals with T2D. The study involves a procedure performed to treat the lining of the first part of the small intestines.

Join the study if you meet the following requirements:

Diagnosed with Type 2 Diabetes
On 2–4 non-insulin glucose-lowering medications or take any one of the GLP-1 medications (Ozempic®, Mounjaro®,Victova®, or Saxenda®)
A1C between 7.5% and 10.5%
Not using insulin

Please fill in your details

Please enter first name.

Please enter last name.

Please enter valid email.

Please enter valid contact number.

Please select type of diabetes.